Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
Zhengchao Lv, Qin Li, Zaixiong Feng, et al.
International Immunopharmacology (2021) Vol. 102, pp. 108383-108383
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
Shabir A. Madhi, Dhayendre Moodley, Sherika Hanley, et al.
The Lancet HIV (2022) Vol. 9, Iss. 5, pp. e309-e322
Open Access | Times Cited: 50
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 31
Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 212-223
Open Access | Times Cited: 31
Research advances in replication-deficient viral vector vaccines
Junna Wang, Jin Cui, Guoxin Li, et al.
Frontiers in Veterinary Science (2025) Vol. 12
Open Access
Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection
Katja Schmidt, Ellen G. Harrer, Koray Taşçılar, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 651-651
Open Access | Times Cited: 23
Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
Xiaoxu Han, Xiaobo Yu, Ying Han, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 2091-2100
Open Access | Times Cited: 21
Booster shot of inactivated SARS‐CoV‐2 vaccine induces potent immune responses in people living with HIV
Haoting Zhan, Huixia Gao, Yongmei Liu, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis
Liangyu Kang, Weijing Shang, Peng Gao, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1569-1569
Open Access | Times Cited: 20
Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
A Systematic Review of COVID-19 Vaccine Antibody Responses in People With HIV
Helen Chun, Kyle Milligan, Elfriede Agyemang, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 17
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Claire Mullender, Kelly A. S. da Costa, Aljawharah Alrubayyi, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 16
T cells in SARS-CoV-2 infection and vaccination
Arthur P. Young
Therapeutic Advances in Vaccines and Immunotherapy (2022) Vol. 10
Open Access | Times Cited: 15
Surrogate neutralization responses following severe acute respiratory syndrome coronavirus 2 vaccination in people with HIV: comparison between inactivated and mRNA vaccine
Ngai Sze Wong, Bonnie C.K. Wong, Jacky Man Chun Chan, et al.
AIDS (2022) Vol. 36, Iss. 9, pp. 1255-1264
Open Access | Times Cited: 13
Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
Songjie Wu, Shi Zou, Fangzhao Ming, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study
Yuxiao Wang, Ying Qiao, Yuqi Huo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
Rhys T Meredith, Max D Bermingham, Kirsten Bentley, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
SARS-CoV-2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination
Xiuwen Wang, Yongzheng Li, Junyan Jin, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 2
Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
Shi Zou, Wei Guo, Songjie Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Systematic review and meta-analysis of COVID-19 vaccines safety, tolerability, and efficacy among HIV-infected patients
Jacques L. Tamuzi, Ley Muyaya Muyaya, Amal K. Mitra, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Advances in Research on COVID-19 Vaccination for People Living with HIV
Junyan Jin, Xiuwen Wang, Raphaël Carapito, et al.
Infectious Diseases & Immunity (2022) Vol. 2, Iss. 4, pp. 213-218
Open Access | Times Cited: 8
A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
Zhengchao Lv, Songqin Lv, Qin Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts
Sorawit Chittrakarn, Pisud Siripaitoon, Sarunyou Chusri, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
CD4 + Count: a Variable to Be Considered to Prioritize COVID-19 Vaccination in PLHIV
Vakada Lakshmi Mounika, Vikash Kumar, Sameer Dhingra, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 2, pp. 90-97
Open Access | Times Cited: 3
Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
Yunyun Yi, Xiaoxu Han, Xinyu Cui, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1019-1019
Open Access | Times Cited: 3
Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis
Tian-Yu Zhao, Zongxing Yang, Yuxia Wu, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top